{"id":86469,"date":"2025-09-26T09:26:07","date_gmt":"2025-09-26T09:26:07","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/86469\/"},"modified":"2025-09-26T09:26:07","modified_gmt":"2025-09-26T09:26:07","slug":"prevalence-and-risk-factors-of-diabetic-kidney-disease-in-malagasy-patients-with-diabetes-mellitus-a-cross-sectional-study-at-a-university-hospital-center-in-antananarivo-madagascar-bmc-nephrology","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/86469\/","title":{"rendered":"Prevalence and risk factors of diabetic kidney disease in Malagasy patients with diabetes mellitus: a cross-sectional study at a University Hospital Center in Antananarivo, Madagascar | BMC Nephrology"},"content":{"rendered":"
  • \n

    Vetrone LM, Zaccardi F, Webb DR, et al. Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis. Acta Diabetol. 2019;56(3):331\u20139. https:\/\/doi.org\/10.1007\/s00592-018-1253-5<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Al-Hajji AA, Alsubaie HA, Albaqshi HT, Al-Hajji HI, AlEssa FMA, Abu Ali BM. Cardiovascular disease-related mortality risk in end stage renal disease and type 2 diabetes: a systematic review. J Family Med Prim Care. 2020;9(7):3195\u20139. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_244_20<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. PharmacoEconomics. 2015;33(8):811\u201331. https:\/\/doi.org\/10.1007\/s40273-015-0268-9<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Walker IF, Garbe F, Wright J, et al. The economic costs of cardiovascular disease, diabetes mellitus, and associated complications in South Asia: a systematic review. Value Health Reg Issues. 2018;15:12\u201326. https:\/\/doi.org\/10.1016\/j.vhri.2017.05.003<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Mutyambizi C, Pavlova M, Chola L, Hongoro C, Groot W. Cost of diabetes mellitus in Africa: a systematic review of existing literature. Global Health. 2018;14(1):3. https:\/\/doi.org\/10.1186\/s12992-017-0318-5<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Pavkov ME, Collins AJ, Coresh J, Nelson RG. Kidney disease in diabetes. In: Cowie CC, Casagrande SS, Menke A, et al, editors. Diabetes in America. 3rd ed. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 22.<\/p>\n<\/li>\n

  • \n

    Lemoine S, Buron F, Fauvel JP. Diabetic n\u00e9phropathy. EMC Endocrinol-Nutrition. 2017;14(2)[Article 10-366-M\u201310].<\/p>\n<\/li>\n

  • \n

    Thomas MC, Brownlee M, Susztak K, et al. Diabetic kidney disease. Nat Rev Dis Primers. 2015;1:15018. https:\/\/doi.org\/10.1038\/nrdp.2015.18<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u201345. https:\/\/doi.org\/10.2215\/CJN.11491116<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Yu J, Liu Y, Li H, Zhang P. Pathophysiology of diabetic kidney disease and autophagy: a review. Med (Baltim). 2023;102(30):e33965. https:\/\/doi.org\/10.1097\/MD.0000000000033965<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Shi S, Ni L, Gao L, Wu X. Comparison of nonalbuminuric and albuminuric diabetic kidney disease among patients with type 2 diabetes: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;13:871272. https:\/\/doi.org\/10.3389\/fendo.2022.871272<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Narres M, Claessen H, Droste S, et al. The incidence of end-stage renal disease in the diabetic (compared to the non-diabetic) population: a systematic review. PLoS One. 2016;11(1):e0147329. https:\/\/doi.org\/10.1371\/journal.pone.0147329<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Oshima M, Shimizu M, Yamanouchi M, et al. Trajectories of kidney function in diabetes: a clinicopathological update. Nat Rev Nephrol. 2021;17(11):740\u201350. https:\/\/doi.org\/10.1038\/s41581-021-00462-y<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V. Chronic kidney disease and the global NCDs agenda. BMJ Glob Health. 2017;2(2):e000380. https:\/\/doi.org\/10.1136\/bmjgh-2017-000380<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Jiang W, Wang J, Shen X, et al. Establishment and validation of a risk prediction model for early diabetic kidney disease based on a systematic review and meta-analysis of 20 cohorts. Diabetes Care. 2020;43(4):925\u201333. https:\/\/doi.org\/10.2337\/dc19-1897<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Noubiap JJ, Naidoo J, Kengne AP. Diabetic nephropathy in Africa: a systematic review. World J Diabetes. 2015;6(5):759\u201373. https:\/\/doi.org\/10.4239\/wjd.v6.i5.759<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Tolossa T, Fetensa G, Regassa B, et al. Burden and determinants of chronic kidney disease among diabetic patients in Ethiopia: a systematic review and meta-analysis. Public Health Rev. 2021;42:1603969. https:\/\/doi.org\/10.3389\/phrs.2021.1603969<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Ranivoharisoa EM, Ramilitiana B, Raherison R, et al. Diabetic nephropathy in Antananarivo, Madagascar: about 207 cases. M\u00e9d Mal M\u00e9tabol. 2016;10(4):358\u201363. https:\/\/doi.org\/10.1016\/S1957-2557(16)30131-6<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Raharinavalona SA, Raherison RE, Miandrisoa RM, Andrianasolo RL, Rakotomalala ADP. Vitamin D status and cardiovascular risk factors in patients with type 2 diabetes mellitus: a cross-sectional study in a tertiary-level hospital in Antananarivo, Madagascar. Diabetes Metab Syndr Obes. 2024;17:2191\u20138. https:\/\/doi.org\/10.2147\/DMSO.S467316<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Authors\/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140\u2013205. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.08.014<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17-S38. https:\/\/doi.org\/10.2337\/dc22-S002<\/a><\/p>\n<\/li>\n

  • \n

    American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S185-S194. https:\/\/doi.org\/10.2337\/dc22-S012<\/a><\/p>\n<\/li>\n

  • \n

    Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association\/american stroke association. Stroke. 2019;50(12):e344\u2013418. https:\/\/doi.org\/10.1161\/STR.0000000000000211<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Raharinavalona SA, Miandrisoa RM, Raherison RE, Razanamparany T, Andrianasolo RL, Rakotomalala ADP. Prevalence and factors associated with carotid atherosclerosis in a Malagasy population with type 2 diabetes mellitus: a cross-sectional retrospective study. Endocrinol Diabetes Metab. 2023;6(6):e457. https:\/\/doi.org\/10.1002\/edm2.457<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Collet JP, Thiele H, Barbato E, ESC Scientific Document Group. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289\u20131367. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa575<\/a><\/p>\n<\/li>\n

  • \n

    Vassalotti JA, Centor R, Turner BJ, National Kidney Foundation Kidney Disease Outcomes Quality Initiative, et al. Practical approach to detection and management of chronic kidney disease for the primary care clinician. Am J Med. 2016;129(2):153\u2013e1627. https:\/\/doi.org\/10.1016\/j.amjmed.2015.08.025<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    American Diabetes Association Professional Practice Committee. 11. Chronic kidney disease and risk management: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S175-S184. https:\/\/doi.org\/10.2337\/dc22-S011<\/a>. Erratum in: Diabetes Care. 2022;45(3):758. https:\/\/doi.org\/10.2337\/dc22-er03<\/a>. Erratum in: Diabetes Care. 2022;45(9):2182\u20132184. https:\/\/doi.org\/10.2337\/dc22-ad08a<\/a>.<\/p>\n<\/li>\n

  • \n

    Naqvi SA, Ahsan S, Fawwad A, Basit A, Shera AS. Effect of angiotensin converting enzyme inhibitor on glomerular hyperfiltration in patients with type 1 diabetes. Pak J Med Sci. 2016;32(3):559\u201364. https:\/\/doi.org\/10.12669\/pjms.323.9399<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Kibirige D, Sekitoleko I, Lumu W. Burden and predictors of diabetic kidney disease in an adult Ugandan population with new-onset diabetes. BMC Res Notes. 2023;16(1):234. https:\/\/doi.org\/10.1186\/s13104-023-06500-1<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Otieno FCF, Ogola EN, Kimando MW, Mutai K. The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a County hospital clinic in kenya: implications to care and need for screening. BMC Nephrol. 2020;21(1):73. https:\/\/doi.org\/10.1186\/s12882-020-1705-3<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Duan J, Wang C, Liu D, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey. Sci Rep. 2019;9(1):10408. https:\/\/doi.org\/10.1038\/s41598-019-46857-7<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Adeniyi OV, Owolabi EO. Cross-sectional study of diabetes kidney disease in the Eastern Cape, South Africa. Med (Baltim). 2020;99(50):e23303. https:\/\/doi.org\/10.1097\/MD.0000000000023303<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Alemu H, Hailu W, Adane A. Prevalence of chronic kidney disease and associated factors among patients with diabetes in northwest Ethiopia: a hospital-based cross-sectional study. Curr Ther Res Clin Exp. 2020;92:100578. https:\/\/doi.org\/10.1016\/j.curtheres.2020.100578<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Wang JS, Yen FS, Lin KD, Shin SJ, Hsu YH, Hsu CC, Diabetes Kidney Disease Research Committee of the Diabetes Association of the Republic of China (Taiwan). Epidemiological characteristics of diabetic kidney disease in Taiwan. J Diabetes Investig. 2021;12(12):2112\u201323. https:\/\/doi.org\/10.1111\/jdi.13668<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Farah RI, Al-Sabbagh MQ, Momani MS, et al. Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study. BMC Nephrol. 2021;22(1):223. https:\/\/doi.org\/10.1186\/s12882-021-02429-4<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Joshi R, Subedi P, Yadav GK, et al. Prevalence and risk factors of chronic kidney disease among patients with type 2 diabetes mellitus at a tertiary care hospital in nepal: a cross-sectional study. BMJ Open. 2023;13(2):e067238. https:\/\/doi.org\/10.1136\/bmjopen-2022-067238<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Lamine F, Lalubin F, Pitteloud N, Burnier M, Zanchi A. Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs. Swiss Med Wkly. 2016;146:w14282. https:\/\/doi.org\/10.4414\/smw.2016.14282<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Janmohamed MN, Kalluvya SE, Mueller A, et al. Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania. BMC Nephrol. 2013;14:183. https:\/\/doi.org\/10.1186\/1471-2369-14-183<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Nazzal Z, Hamdan Z, Masri D, Abu-Kaf O, Hamad M. Prevalence and risk factors of chronic kidney disease among Palestinian type 2 diabetic patients: a cross-sectional study. BMC Nephrol. 2020;21(1):484. https:\/\/doi.org\/10.1186\/s12882-020-02138-4<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Fiseha T, Tamir Z. Prevalence and awareness of chronic kidney disease among adult diabetic outpatients in northeast Ethiopia. BMC Nephrol. 2020;21(1):129. https:\/\/doi.org\/10.1186\/s12882-020-01768-y<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    De Cosmo S, Viazzi F, Pacilli A, the AMD-Annals Study Group. Predictors of chronic kidney disease in type 2 diabetes: a longitudinal study from the AMD annals initiative. Med (Baltim). 2016;95(27):e4007. https:\/\/doi.org\/10.1097\/MD.0000000000004007<\/a><\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Duan JY, Duan GC, Wang CJ, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey. BMC Nephrol. 2020;21(1):115. https:\/\/doi.org\/10.1186\/s12882-020-01761-5<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Liu J, Liu Z, Sun W, et al. Role of sex hormones in diabetic nephropathy. Front Endocrinol (Lausanne). 2023;14:1135530. https:\/\/doi.org\/10.3389\/fendo.2023.1135530<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Yang J, Liu Z. Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front Endocrinol (Lausanne). 2022;13:816400. https:\/\/doi.org\/10.3389\/fendo.2022.816400<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Mishriky BM, Cummings DM, Powell JR. Diabetes-related microvascular complications – a practical approach. Prim Care. 2022;49(2):239\u201354. https:\/\/doi.org\/10.1016\/j.pop.2021.11.008<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Maqbool M, Cooper ME, Jandeleit-Dahm KAM. Cardiovascular disease and diabetic kidney disease. Semin Nephrol. 2018;38(3):217\u201332. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.02.003<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Molitch ME, Gao X, Bebu I, Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Research Group, et al. Early glomerular hyperfiltration and long-term kidney outcomes in type 1 diabetes: the DCCT\/EDIC experience. Clin J Am Soc Nephrol. 2019;14(6):854\u201361. https:\/\/doi.org\/10.2215\/CJN.14831218<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Moriconi D, Sacchetta L, Chiriac\u00f2 M, et al. Glomerular hyperfiltration predicts kidney function decline and mortality in type 1 and type 2 diabetes: a 21-year longitudinal study. Diabetes Care. 2023;46(4):845\u201353. https:\/\/doi.org\/10.2337\/dc22-2003<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Tonneijck L, Muskiet MH, Smits MM, et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 2017;28(4):1023\u201339. https:\/\/doi.org\/10.1681\/ASN.2016060666<\/a>.<\/p>\n

    Article<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n","protected":false},"excerpt":{"rendered":"Vetrone LM, Zaccardi F, Webb DR, et al. Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes…\n","protected":false},"author":2,"featured_media":86470,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[78],"tags":[8294,56988,18,56989,135,19,1911,17,56990,21821,3027],"class_list":{"0":"post-86469","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-diabetes-mellitus","9":"tag-diabetic-kidney-disease","10":"tag-eire","11":"tag-glomerular-hyperfiltration","12":"tag-health","13":"tag-ie","14":"tag-internal-medicine","15":"tag-ireland","16":"tag-nephrology","17":"tag-prevalence","18":"tag-risk-factors"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/86469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=86469"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/86469\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/86470"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=86469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=86469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=86469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}